Vertex is just a few weeks away from hearing the FDA's verdict on its cystic fibrosis (CF) therapy Orkambi, so the publication of clinical trial data in a prestigious journal comes at an opportune ...

An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...

No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

"4DMT reveals positive interim Phase I/II data for cystic fibrosis gene therapy" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this ...

The UAB Gregory Fleming James Cystic Fibrosis Research Center is a university-wide interdisciplinary research center funded by the National Institutes of Health, the Cystic Fibrosis Foundation, and ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

today announced that interim data from the Phase 1/2 AEROW clinical trial evaluating aerosolized 4D-710 for treatment of cystic fibrosis lung disease will be presented at the 47 th European Cystic ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

in lung function improvement with an acceptable safety profile in patients with cystic fibrosis. Researchers conducted two randomized, double-blind phase 3 trials (SKYLINE VX20-121-102 and VX20 ...

Cystic fibrosis (CF) is a genetic condition that ... A small 2021 study analyzed data from 119 endoscopic sinus surgeries performed on 88 people over 6 years. The researchers focused on changes ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...